Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 234, Issue 3, Pages 398-409
Publisher
Wiley
Online
2014-07-26
DOI
10.1002/path.4411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-α–Induced TGF-α Expression and MEK/VEGF-A–Mediated Angiogenesis
- (2013) Li-Hsun Chang et al. AMERICAN JOURNAL OF PATHOLOGY
- Therapeutic Efficacy of Bifunctional siRNA Combining TGF- 1 Silencing with RIG-I Activation in Pancreatic Cancer
- (2013) J. Ellermeier et al. CANCER RESEARCH
- Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis
- (2013) Masataka Matsumoto et al. CLINICAL & EXPERIMENTAL METASTASIS
- PI3K activates integrin 4 1 to establish a metastatic niche in lymph nodes
- (2013) B. Garmy-Susini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer
- (2012) J.-G. Wang et al. BLOOD
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Genomic Sequencing of Key Genes in Mouse Pancreatic Cancer Cells
- (2012) Y. Wang et al. CURRENT MOLECULAR MEDICINE
- Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype
- (2012) Zhiwei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer
- (2011) Andrew S. Epstein et al. CANCER
- Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
- (2011) V. Patel et al. CANCER RESEARCH
- A Syngeneic Orthotopic Murine Model of Pancreatic Adenocarcinoma in the C57/BL6 Mouse Using the Panc02 and 6606PDA Cell Lines
- (2011) L.I. Partecke et al. EUROPEAN SURGICAL RESEARCH
- Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer
- (2011) Shadan Ali et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
- (2011) Frederiek F. van Doormaal et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Immunocompetent Murine Models Representing Advanced Local and Metastatic Pancreatic Cancer
- (2011) Elizabeth C. Little et al. JOURNAL OF SURGICAL RESEARCH
- Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma
- (2011) P. Olson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protease-activated receptor 2 signaling in inflammation
- (2011) Andrea S. Rothmeier et al. Seminars in Immunopathology
- Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury
- (2010) Keren Borensztajn et al. AMERICAN JOURNAL OF PATHOLOGY
- Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development
- (2010) F. Schaffner et al. BLOOD
- Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
- (2010) Sean P. Dineen et al. CANCER RESEARCH
- PRSS3 promotes tumour growth and metastasis of human pancreatic cancer
- (2010) G. Jiang et al. GUT
- Heparin and Survival in Cancer Patients
- (2010) Frederiek F. van Doormaal et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders
- (2009) Lois W. Brüggemann et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Real-Time High-Resolution Compound Imaging Allows Percutaneous Initiation and Surveillance in an Orthotopic Murine Pancreatic Cancer Model
- (2009) Carsten Ziske et al. PANCREAS
- TGF-β1 is a negative regulator of lymphatic regeneration during wound repair
- (2008) Nicholas W. Clavin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
- (2008) F Rückert et al. BRITISH JOURNAL OF CANCER
- Protease-Activated Receptor (PAR) 2, but not PAR1, Signaling Promotes the Development of Mammary Adenocarcinoma in Polyoma Middle T Mice
- (2008) H. H. Versteeg et al. CANCER RESEARCH
- Heparin as an anticancer therapeutic
- (2008) Leo R Zacharski et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?
- (2008) Keren Borensztajn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started